Kevin Punie

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Aditya Bardia, Sara A. Hurvitz, Sara M. Tolaney et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Elizabeth A. Mittendorf, Hong Zhang, Carlos H. Barrios et al. · The Lancet · 2020 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +16

A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer

Ayse Bassez, Hanne Vos, Laurien Van Dyck et al. · Nature Medicine · 2021 · 915 citations · Full text

Medicine, Cancer Biology, Oncology +17

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Fátima Cardoso, John M.S. Bartlett, Leen Slaets et al. · Annals of Oncology · 2017 · 399 citations · Full text

Medicine, Oncology, Surgery +15

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

Aditya Bardia, Sara M. Tolaney, Kevin Punie et al. · Annals of Oncology · 2021 · 299 citations · Full text

Medicine, Oncology, Pharmacology +16